Department of Physiology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Ital J Pediatr. 2010 May 25;36:39. doi: 10.1186/1824-7288-36-39.
In beta-thalassemia, profound anemia and severe hemosiderosis cause functional and physiological abnormalities in various organ systems. In recent years, there have been few published studies mainly in adult demonstrating renal involvement in beta-thalassemia. This prospective study was aimed to investigate renal involvement in pediatric patients with transfusion dependent beta-thalassemia major (TD-betaTM), using both conventional and early markers of glomerular and tubular dysfunctions, and to correlate findings to oxidative stress and iron chelation therapy.
Sixty-nine TD-betaTM patients (aged 1-16 years) and 15 healthy controls (aged 3-14 years) were enrolled in this study. Based on receiving chelation therapy (deferoxamine, DFO), patients were divided into two groups: group [I] with chelation (n=34) and group [II] without chelation (n=35). Levels of creatinine (Cr), calcium (Ca), inorganic phosphorus (PO4), uric acid (UA) and albumin were measured by spectrophotometer. Serum (S) levels of cystatin-C (SCysC) and total antioxidant capacity (STAC) and urinary (U) levels of beta2-microglobulin (Ubeta2MG) were measured by immunosorbent assay (ELISA). Urinary N-acetyl-beta-D-glucosaminidase (UNAG) activity and malondialdehyde (UMDA) were measured by chemical methods. Estimated glomerular filtration rate (eGFR) was determined from serum creatinine.
In patient with and without chelation, glomerular [elevated SCysC, SCr, Ualbumin/Cr and diminished eGFR]; and tubular dysfunctions [elevated SUA, SPO4, UNAG/Cr, Ubeta2MG/Cr] and oxidative stress marker disturbances [diminished STAC and elevated UMDA/Cr] were reported than controls. In patients with chelation, SCysC was significantly higher while, STAC was significantly lower than those without chelation. In all patients, SCysC showed significant positive correlation with SCr and negative correlation with eGFR; STAC showed significant positive correlation with eGFR and negative correlation with SCysC, SCr, UNAG/Cr; UMDA/Cr showed significant positive correlation with Ualbumin/Cr, Ubeta2MG/Cr, UNAG/Cr.
Our data confirm high frequency of glomerular and tubular dysfunctions in TD-betaTM pediatric patients which could be attributed to oxidative stress and DFO therapy.
在β地中海贫血中,严重的贫血和严重的血色素沉着症导致各种器官系统的功能和生理异常。近年来,很少有主要针对成人的发表研究表明β地中海贫血存在肾脏受累。本前瞻性研究旨在使用肾小球和肾小管功能障碍的常规和早期标志物来研究依赖输血的β地中海贫血重型(TD-βTM)儿科患者的肾脏受累情况,并将发现与氧化应激和铁螯合治疗相关联。
本研究纳入 69 例 TD-βTM 患者(年龄 1-16 岁)和 15 例健康对照者(年龄 3-14 岁)。根据接受螯合治疗(去铁胺,DFO),患者分为两组:有螯合组(n=34)和无螯合组(n=35)。分光光度计法测定血清肌酐(Cr)、钙(Ca)、无机磷(PO4)、尿酸(UA)和白蛋白水平。免疫吸附测定法(ELISA)测定血清胱抑素-C(SCysC)和总抗氧化能力(STAC)及尿β2-微球蛋白(Ubeta2MG)水平。化学法测定尿 N-乙酰-β-D-氨基葡萄糖苷酶(UNAG)活性和丙二醛(UMDA)。根据血清肌酐计算估计肾小球滤过率(eGFR)。
在有螯合和无螯合的患者中,肾小球[升高的 SCysC、SCr、Ualbumin/Cr 和降低的 eGFR];和肾小管功能障碍[升高的 SUA、SPO4、UNAG/Cr、Ubeta2MG/Cr]以及氧化应激标志物紊乱[降低的 STAC 和升高的 UMDA/Cr]均较对照组更明显。在接受螯合治疗的患者中,SCysC 明显高于无螯合组,而 STAC 明显低于无螯合组。在所有患者中,SCysC 与 SCr 呈正相关,与 eGFR 呈负相关;STAC 与 eGFR 呈正相关,与 SCysC、SCr、UNAG/Cr 呈负相关;UMDA/Cr 与 Ualbumin/Cr、Ubeta2MG/Cr、UNAG/Cr 呈正相关。
我们的数据证实 TD-βTM 儿科患者肾小球和肾小管功能障碍的发生率较高,这可能归因于氧化应激和 DFO 治疗。